Mutations in gyrA & parC genes of Shigella flexneri 2a determining the fluoroquinolone resistance.
作者信息
Divya M P, Mathew P Deepa, Jyothi R, Bai Ramani, Thomas Sabu
机构信息
Cholera & Environmental Microbiology Laboratory, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram 695 014, India.
出版信息
Indian J Med Res. 2015 Jun;141(6):836-8. doi: 10.4103/0971-5916.160722.
Abstract
摘要
相似文献
1
Mutations in gyrA & parC genes of Shigella flexneri 2a determining the fluoroquinolone resistance.
Indian J Med Res. 2015 Jun;141(6):836-8. doi: 10.4103/0971-5916.160722.
2
Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China.
J Antimicrob Chemother. 2009 May;63(5):917-20. doi: 10.1093/jac/dkp087. Epub 2009 Mar 18.
3
Resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in Shigella flexneri and Shigella sonnei strains isolated in Korea.
Clin Microbiol Infect. 2008 Aug;14(8):760-5. doi: 10.1111/j.1469-0691.2008.02033.x.
4
5
Fluoroquinolone resistance linked to both gyrA and parC mutations in the quinolone resistance-determining region of Shigella dysenteriae type 1.
Curr Microbiol. 2006 Feb;52(2):108-11. doi: 10.1007/s00284-005-0140-9. Epub 2006 Jan 31.
6
Structural Insights into the Fluoroquinolone Resistance Mechanism of Shigella flexneri DNA Gyrase and Topoisomerase IV.
Microb Drug Resist. 2016 Jul;22(5):404-11. doi: 10.1089/mdr.2015.0018. Epub 2016 Feb 9.
7
Fluoroquinolone Resistance Mechanisms in Shigella Isolates in Shanghai, China, Between 2010 and 2015.
Microb Drug Resist. 2019 Mar;25(2):212-218. doi: 10.1089/mdr.2018.0113. Epub 2018 Oct 10.
8
Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in Quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India.
Antimicrob Agents Chemother. 2005 Apr;49(4):1660-1. doi: 10.1128/AAC.49.4.1660-1661.2005.
9
Wide dissemination of multidrug-resistant Shigella isolates in China.
J Antimicrob Chemother. 2011 Nov;66(11):2527-35. doi: 10.1093/jac/dkr341. Epub 2011 Aug 22.
10
Novel mutations in quinolone resistance-determining regions of gyrA, gyrB, parC and parE in Shigella flexneri clinical isolates from eastern Chinese populations between 2001 and 2011.
Eur J Clin Microbiol Infect Dis. 2016 Dec;35(12):2037-2045. doi: 10.1007/s10096-016-2761-2. Epub 2016 Sep 12.
本文引用的文献
1
The Recent Trends of Shigellosis: A JIPMER Perspective.
J Clin Diagn Res. 2012 Nov;6(9):1474-7. doi: 10.7860/JCDR/2012/4157.2536.
2
Wide dissemination of multidrug-resistant Shigella isolates in China.
J Antimicrob Chemother. 2011 Nov;66(11):2527-35. doi: 10.1093/jac/dkr341. Epub 2011 Aug 22.
3
Decrease in shigellosis-related deaths without Shigella spp.-specific interventions, Asia.
Emerg Infect Dis. 2010 Nov;16(11):1718-23. doi: 10.3201/eid1611.090934.
4
Atypical class 1 integron coexists with class 1 and class 2 integrons in multi-drug resistant Shigella flexneri isolates from China.
Curr Microbiol. 2011 Mar;62(3):802-6. doi: 10.1007/s00284-010-9790-3. Epub 2010 Oct 26.
5
Subtype prevalence, plasmid profiles and growing fluoroquinolone resistance in Shigella from Kolkata, India (2001-2007): a hospital-based study.
Trop Med Int Health. 2010 Dec;15(12):1499-507. doi: 10.1111/j.1365-3156.2010.02656.x. Epub 2010 Oct 18.
6
Plasmid-mediated quinolone resistance: a multifaceted threat.
Clin Microbiol Rev. 2009 Oct;22(4):664-89. doi: 10.1128/CMR.00016-09.
7
Magnitude of drug resistant Shigellosis: a report from Bangalore.
Indian J Med Microbiol. 2009 Oct-Dec;27(4):358-60. doi: 10.4103/0255-0857.55460.
8
Shigellosis in Puducherry.
Indian J Med Res. 2008 Jun;127(6):621-2.
9
Molecular characterization of multidrug-resistant Shigella species isolated from epidemic and endemic cases of shigellosis in India.
J Med Microbiol. 2008 Jul;57(Pt 7):856-863. doi: 10.1099/jmm.0.2008/000521-0.
10
Shigellosis: the current status of vaccine development.
Curr Opin Infect Dis. 2008 Jun;21(3):313-8. doi: 10.1097/QCO.0b013e3282f88b92.
Zotero 插件